Galmed Pharmaceuticals
(NASDAQ) GLMD
Galmed Pharmaceuticals Financials at a Glance
Market Cap
$2.77M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.70M
EPS (TTM)
$-3.53
P/E Ratio
-0.14
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.61
Volume
0
Open
$0.61
Price
$0.61
Volume
0
Open
$0.61
Previous Close
$0.61
Daily Range
$0.61 - $0.61
52-Week Range
$0.41 - $2.68
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$0.61
Volume
0
Open
$0.61
Previous Close
$0.61
Daily Range
$0.61 - $0.61
52-Week Range
$0.41 - $2.68
GLMD News
GLMD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Galmed Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Allen Baharaff
Website
galmedpharma.comHeadquarters
Ramat Gan, 6578317, IL
GLMD Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-46%
Return on Capital
-37%
Return on Assets
-40%
Earnings Yield
-7.14%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.77M
Shares Outstanding
5.48M
Volume
0
Short Interest
0.00%
Avg. Volume
60.46K
Financials (TTM)
Gross Profit
$83.00K
Operating Income
$6.28M
EBITDA
$7.42M
Operating Cash Flow
$5.88M
Capital Expenditure
$0.00
Free Cash Flow
$5.88M
Cash & ST Invst.
$15.33M
Total Debt
$0.00
Galmed Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.77M
N/A
Market Cap/Employee
$921.97K
N/A
Employees
3
N/A
Net Income
$1.89M
+1.1%
EBITDA
$2.07M
-3.1%
Quarterly Fundamentals
Net Cash
$19.05M
+11.1%
Accounts Receivable
$549.00K
+28.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-40.31%
N/A
Return on Invested Capital
-36.80%
N/A
Free Cash Flow
$1.94M
-81.9%
Operating Cash Flow
$1.94M
-81.9%